cheap propecia
cheap propecia
The NAD (Nanoparticles for therapy and diagnosis of Alzheimer's disease) Project is aiming tocheap propecia. The research is financed by the European Union's 7th Framework Program and includes . Grant agreement no: CP-IP 212043-2 NAD. cheap propecia.
Recent statistics indicate that cheap propecia are affected by dementia with cheap propecia (one new case every 7 seconds). cheap propecia. Given the continuing increase in life expectancy, these numbers are expected to rise dramatically. In 2040 cases are expected to double in Western Europe and to triple in Eastern Europe. Despite great progress in the scientific field, which has made interpretation of the molecular bases of the disease possible, there has been little progress in diagnosis and therapy.
The goal of the study, developed in the field of nanotechnologies, is to cheap propecia to reach the brain, principal site of Alzheimer's disease. Molecules that can recognize (diagnosis) and destroy (therapy) the amyloid deposits, characteristic of the illness, will be attached to the nanoparticles, and tested on animal models of the disease (transgenic mice). If the expectations of the research are attained, future experiments can be performed on humans. The results can have an enormous impact on thecheap propeciaof a disease of high incidence, which takes a heavy social cost.








